Scarica l'app Stockscreener
8.22
0.72%
-0.06
Dopo l'orario di chiusura:
8.60
0.38
+4.62%
Precedente Chiudi:
$8.28
Aprire:
$8.37
Volume 24 ore:
11,372
Relative Volume:
0.12
Capitalizzazione di mercato:
$283.01M
Reddito:
$4.71M
Utile/perdita netta:
$-46.77M
Rapporto P/E:
-4.8952
EPS:
-1.6792
Flusso di cassa netto:
$-60.34M
1 W Prestazione:
+8.73%
1M Prestazione:
+6.48%
6M Prestazione:
-24.66%
1 anno Prestazione:
-9.74%
Intervallo 1D:
$8.10
$8.37
Intervallo di 1 settimana:
$7.52
$8.37
Portata 52W:
$5.55
$11.87
Nyxoah Sa Stock (NYXH) Company Profile
Nome
Nyxoah Sa
Settore
Industria
Telefono
-
Indirizzo
-
Confronta NYXH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
8.22 | 283.01M | 4.71M | -46.77M | -60.34M | -1.6792 |
|
ISRG
Intuitive Surgical Inc
|
518.62 | 183.53B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
178.85 | 50.43B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.35 | 43.27B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
257.92 | 37.30B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
210.89 | 16.32B | 2.90B | 467.20M | 306.90M | 6.37 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-07-31 | Iniziato | H.C. Wainwright | Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Neutral |
| 2022-04-21 | Iniziato | Oppenheimer | Outperform |
| 2022-04-06 | Iniziato | Wolfe Research | Peer Perform |
| 2021-12-21 | Ripresa | Cantor Fitzgerald | Overweight |
| 2021-07-28 | Iniziato | Cantor Fitzgerald | Overweight |
Mostra tutto
Nyxoah Sa Borsa (NYXH) Ultime notizie
Is Nyxoah SA a good long term investmentDouble-digit growth - Jammu Links News
What analysts say about Nyxoah SA stockConsistent triple returns - Jammu Links News
Nyxoah SA Stock Analysis and ForecastPhenomenal returns - Jammu Links News
Nyxoah’s Innovative Approach to Sleep Apnea: A Clinical Study Update - TipRanks
Is Nyxoah SA stock a growth or value playControlled Risk High Reward Plan - Newser
What makes Nyxoah SA stock price move sharplyShort Squeeze Radar - Newser
Why Nyxoah SA stock attracts strong analyst attentionFree Access to Investment Community - Newser
How Nyxoah SA stock performs during market volatilitySmart High Yield Swing Trades - Newser
(NYXH) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 2, 2025 - yahoo.co
Major Governance Shift: Nyxoah Grants Long-term Shareholders New Board Nomination Rights - Stock Titan
Cantor Fitzgerald Forecasts Nyxoah FY2026 Earnings - Defense World
Ameriprise Financial Inc. Takes $135,000 Position in Nyxoah S.A. (NASDAQ:NYXH) - Defense World
When the Price of (NYXH) Talks, People Listen - news.stocktradersdaily.com
Top Premarket Decliners - marketscreener.com
Millennium Management LLC Trims Stock Holdings in Nyxoah S.A. (NASDAQ:NYXH) - Defense World
Nyxoah Announces Change in Shareholder Voting Rights - TipRanks
Vestal Point Capital Cuts Nyxoah Holdings by 40%: Major Ownership Shift Revealed - Stock Titan
Nyxoah to Present at the Jefferies Global Healthcare Conference - The Manila Times
Nyxoah CEO Showcases Revolutionary Sleep Apnea Treatment at Major Jefferies Healthcare Conference - Stock Titan
Nyxoah SA Updates Share Capital and Voting Rights - TipRanks
Information on the total number of voting rights and shares - Yahoo
Head-To-Head Survey: Inspire Medical Systems (NYSE:INSP) versus Nyxoah (NASDAQ:NYXH) - Defense World
Cantor maintains Nyxoah stock Overweight with $14 target By Investing.com - Investing.com Nigeria
Nyxoah Announces CE Mark Approval For Genio® 2.1 - Barchart.com
Cantor maintains Nyxoah stock Overweight with $14 target - Investing.com
Nyxoah SA (NYXH) Reports Q1 Loss, Lags Revenue Estimates - MSN
Trading (NYXH) With Integrated Risk Controls - news.stocktradersdaily.com
Nyxoah Sa’s Earnings Call: Progress Amid Challenges - TipRanks
Nyxoah outlines U.S. Genio launch plan with 50-member team as FDA approval expected Q2 2025 - MSN
Nyxoah S.A. (NASDAQ:NYXH) Q1 2025 Earnings Call Transcript - Insider Monkey
Nyxoah Reports Q1 2025 Financial Results and FDA Progress - TipRanks
Nyxoah Q1 2025 Earnings Call Transcript - MarketBeat
Nyxoah Nears FDA Approval for Genio® System Amid Q1 2025 Results - TipRanks
Nyxoah (NYXH) Nears FDA Approval for Genio System in the U.S. | - GuruFocus
Nyxoah reports Q1 EPS (EUR 0.60) vs. (EUR 0.42) last year - TipRanks
Nyxoah Reports First Quarter Financial and Operating Results - The Manila Times
Nyxoah Nears FDA Approval for Sleep Apnea Device as Q1 Revenue Hits €1.1M | NYXH Stock News - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Nyxoah S.A. – NYXH - Bluefield Daily Telegraph
Earnings To Watch: Nyxoah SA (NYXH) Reports Q1 2025 Result - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A.NYXH - PR Newswire
Nyxoah (NYXH) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Nyxoah Sa Azioni (NYXH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):